R-116010 structure
|
Common Name | R-116010 | ||
---|---|---|---|---|
CAS Number | 355860-40-1 | Molecular Weight | 377.506 | |
Density | 1.2±0.1 g/cm3 | Boiling Point | 569.7±60.0 °C at 760 mmHg | |
Molecular Formula | C21H23N5S | Melting Point | N/A | |
MSDS | N/A | Flash Point | 298.4±32.9 °C |
Use of R-116010A potent CYP26A1 inhibitor with IC50 of 10 nM, potently inhibits all-trans-retinoic acid metabolism in intact T47D cells with IC50 of 8.7 nM; enhances the ATRA-mediated antiproliferative activity in a concentration-dependent manner, significantly inhibits the growth of murine oestrogen-independent TA3-Ha mammary tumour in vivo. |
Name | N1-(1,3-Benzothiazol-2-yl)-4-[(1S)-1-(1H-imidazol-1-yl)propyl]-N2,N2-dimethyl-1,2-benzenediamine |
---|---|
Synonym | More Synonyms |
Description | A potent CYP26A1 inhibitor with IC50 of 10 nM, potently inhibits all-trans-retinoic acid metabolism in intact T47D cells with IC50 of 8.7 nM; enhances the ATRA-mediated antiproliferative activity in a concentration-dependent manner, significantly inhibits the growth of murine oestrogen-independent TA3-Ha mammary tumour in vivo. |
---|---|
References | References 1. Thatcher JE, et al. Mol Pharmacol. 2011 Aug;80(2):228-39. 2. Van Heusden J, et al. Br J Cancer. 2002 Feb 12;86(4):605-11. View Related Products by Target Cytochrome P450 (CYPs) |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 569.7±60.0 °C at 760 mmHg |
Molecular Formula | C21H23N5S |
Molecular Weight | 377.506 |
Flash Point | 298.4±32.9 °C |
Exact Mass | 377.167419 |
LogP | 4.19 |
Vapour Pressure | 0.0±1.6 mmHg at 25°C |
Index of Refraction | 1.669 |
1,2-Benzenediamine, N1-2-benzothiazolyl-4-[(1S)-1-(1H-imidazol-1-yl)propyl]-N2,N2-dimethyl- |
N1-(1,3-Benzothiazol-2-yl)-4-[(1S)-1-(1H-imidazol-1-yl)propyl]-N2,N2-dimethyl-1,2-benzenediamine |